Childhood adversity and clinical and psychosocial outcomes in psychosis

por Turner, S., Harvey, C., Hayes, L., Castle, D., Galletly, C., Sweeney, S., Shah, S., Keogh, L., Spittal, M. J.
Publicado 2019

Autoantibody profiles are associated with specific clinical features in psychotic disorders

por Schubert, K.O., Falk, A. Jernbom, Galletly, C., Just, D., Toben, C., Baune, B., Clark, S., Liu, D., Nilsson, P., Manberg, A.
Publicado 2021

Brain antibodies in the cortex and blood of people with schizophrenia and controls

por Glass, L J, Sinclair, D, Boerrigter, D, Naude, K, Fung, S J, Brown, D, Catts, V S, Tooney, P, O'Donnell, M, Lenroot, R, Galletly, C, Liu, D, Weickert, T W, Shannon Weickert, C
Publicado 2017

Adjunctive raloxifene treatment improves attention and memory in men and women with schizophrenia

por Weickert, T W, Weinberg, D, Lenroot, R, Catts, S V, Wells, R, Vercammen, A, O'Donnell, M, Galletly, C, Liu, D, Balzan, R, Short, B, Pellen, D, Curtis, J, Carr, V J, Kulkarni, J, Schofield, P R, Weickert, C S
Publicado 2015

Psychosis prevalence and physical, metabolic and cognitive co-morbidity: data from the second Australian national survey of psychosis

por Morgan, V. A., McGrath, J. J., Jablensky, A., Badcock, J. C., Waterreus, A., Bush, R., Carr, V., Castle, D., Cohen, M., Galletly, C., Harvey, C., Hocking, B., McGorry, P., Neil, A. L., Saw, S., Shah, S., Stain, H. J., Mackinnon, A.
Publicado 2014